Clinical Trials Directory

Trials / Conditions / Recurrent Childhood Visual Pathway and Hypothalamic Glioma

Recurrent Childhood Visual Pathway and Hypothalamic Glioma

17 registered clinical trials studyying Recurrent Childhood Visual Pathway and Hypothalamic Glioma.

StatusTrialSponsorPhase
Terminated18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas
NCT02175745
Erik MittraN/A
WithdrawnEfficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
NCT02194452
Sue O'DorisioN/A
TerminatedGamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS T
NCT01088763
National Cancer Institute (NCI)Phase 1
CompletedVorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spi
NCT01076530
National Cancer Institute (NCI)Phase 1
CompletedVorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Cent
NCT00994500
National Cancer Institute (NCI)Phase 1
CompletedABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors
NCT00946335
National Cancer Institute (NCI)Phase 1
CompletedCilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responde
NCT00679354
National Cancer Institute (NCI)Phase 2
CompletedBusulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagn
NCT00638898
City of Hope Medical CenterPhase 1
CompletedIspinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma
NCT00363272
National Cancer Institute (NCI)Phase 1
CompletedLenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors
NCT00100880
National Cancer Institute (NCI)Phase 1
CompletedOxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatme
NCT00091182
National Cancer Institute (NCI)Phase 2
CompletedTipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primit
NCT00070525
National Cancer Institute (NCI)Phase 2
CompletedCilengitide in Treating Children With Refractory Primary Brain Tumors
NCT00063973
National Cancer Institute (NCI)Phase 1
CompletedTemozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors
NCT00052780
National Cancer Institute (NCI)Phase 1
CompletedFR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia
NCT00053963
National Cancer Institute (NCI)Phase 1
CompletedFlavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas
NCT00012181
National Cancer Institute (NCI)Phase 1
CompletedIrinotecan in Treating Children With Refractory Solid Tumors
NCT00004078
Children's Oncology GroupPhase 2